Brief: China NT Pharma Group Company Posts Loss For Year Attributable RMB66.4 Mln
31/03/2023 16:22
March 31 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* LOSS FOR YEAR ATTRIBUTABLE RMB66.4 MILLION VERSUS LOSS
RMB149.5
MILLION
* FY REVENUE RMB207.1 MILLION VERSUS RMB226.7 MILLION
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY